PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 22 filers reported holding PHARVARIS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 4.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,743,450 | $78,125,802 | 43.39% |
| venBio Partners LLC | 4,264,672 | $89,003,705 | 25.24% |
| Bain Capital Life Sciences Investors, LLC | 4,784,674 | $99,856,146 | 11.17% |
| 5AM Venture Management, LLC | 587,600 | $12,263,212 | 3.53% |
| VR Adviser, LLC | 1,563,513 | $32,630,516 | 3.44% |
| Novo Holdings A/S | 1,329,325 | $27,743,013 | 2.05% |
| Cormorant Asset Management, LP | 1,361,460 | $28,413,670 | 1.66% |
| GENERAL ATLANTIC, L.P. | 4,406,252 | $91,958,479 | 1.42% |
| Foresite Capital Management V, LLC | 33,142 | $691,674 | 1.10% |
| Soleus Capital Management, L.P. | 343,975 | $7,178,758 | 0.66% |
| VIKING GLOBAL INVESTORS LP | 3,231,923 | $67,450,233 | 0.27% |
| Y-Intercept (Hong Kong) Ltd | 17,553 | $366,331 | 0.04% |
| FMR LLC | 3,207,564 | $66,941,861 | 0.01% |
| Hudson Bay Capital Management LP | 77,786 | $1,623,394 | 0.01% |
| Walleye Capital LLC | 81,017 | $1,690,825 | 0.00% |
| Schonfeld Strategic Advisors LLC | 11,900 | $248,353 | 0.00% |
| UBS Group AG | 50 | $1,044 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,595 | $450,687 | 0.00% |
| MORGAN STANLEY | 33,697 | $703,256 | 0.00% |
External links
This page lists PHARVARIS N V's shareholders in Q3 2023. To view PHARVARIS N V's shareholder history, click here.